Improved antibacterial activity of a sustained-release biocompatible nanofilm for treating Pseudomonas aeruginosa wound infection in vitro and in vivo
ObjectivesThe primary goal of this research was to design a useful and biocompatible nanofilm system (CNF) encapsulating chlorhexidine acetate (CHX) for wounds that is endowed with antibacterial and anti-inflammatory activities and promotes wound healing.MethodsThe nanofilm system was developed on t...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1548106/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850215807633588224 |
|---|---|
| author | Feifei Lu Guoxiu Lu Zhiguo Wang Wenzhua Wei Jingjing Chen Hailin Zheng Xuesong Liu Yan Ye Shuling Liu Yuxiang Lin Yuxin Liu Zhanhua Bi Quanming Zou Guoxu Zhang Guoxu Zhang Hongwu Sun Yanan Tong |
| author_facet | Feifei Lu Guoxiu Lu Zhiguo Wang Wenzhua Wei Jingjing Chen Hailin Zheng Xuesong Liu Yan Ye Shuling Liu Yuxiang Lin Yuxin Liu Zhanhua Bi Quanming Zou Guoxu Zhang Guoxu Zhang Hongwu Sun Yanan Tong |
| author_sort | Feifei Lu |
| collection | DOAJ |
| description | ObjectivesThe primary goal of this research was to design a useful and biocompatible nanofilm system (CNF) encapsulating chlorhexidine acetate (CHX) for wounds that is endowed with antibacterial and anti-inflammatory activities and promotes wound healing.MethodsThe nanofilm system was developed on the basis of the successful preparation of its nanoemulsion and PVA-CS film system and then important properties of the nanofilm system, including its morphological and physicochemical characteristics, stability and safety, its antimicrobial efficacy against P. aeruginosa was also evaluated in vitro and in vivo. The antibacterial effect, wound healing effect and inflammatory factor change in vivo were evaluated.ResultsThese results of this nanofilm system revealed a good particle size (59.27 nm) and stable zeta potential (−15.2 mV) that are suitable for wound healing applications. Additionally, it was stable, exhibited long-term stability (24 months) and sustained release in simulated wound fluid. Results showed that this nanofilm does not induce dose-related toxic effects and displays a better antibacterial effect that occurs more quickly, two times greater than that of CHX in vitro. This safe nanofilm enhances antibacterial activity against P. aeruginosa for 14 days, modulates the immune response, and accelerates skin wound healing in vivo.ConclusionsThese insights into multifunctional nanofilm designs for improved antibacterial effects and sustained release suggest promising clinical applications. |
| format | Article |
| id | doaj-art-064ae0dad8c94e37a4287e051334ac74 |
| institution | OA Journals |
| issn | 1664-302X |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Microbiology |
| spelling | doaj-art-064ae0dad8c94e37a4287e051334ac742025-08-20T02:08:30ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2025-04-011610.3389/fmicb.2025.15481061548106Improved antibacterial activity of a sustained-release biocompatible nanofilm for treating Pseudomonas aeruginosa wound infection in vitro and in vivoFeifei Lu0Guoxiu Lu1Zhiguo Wang2Wenzhua Wei3Jingjing Chen4Hailin Zheng5Xuesong Liu6Yan Ye7Shuling Liu8Yuxiang Lin9Yuxin Liu10Zhanhua Bi11Quanming Zou12Guoxu Zhang13Guoxu Zhang14Hongwu Sun15Yanan Tong16College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, Liaoning, ChinaCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, Liaoning, ChinaDepartment of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, ChinaNational Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, ChinaNational Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, ChinaNational Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, ChinaNational Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, ChinaNational Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, ChinaNational Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, ChinaDepartment of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, ChinaDepartment of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, ChinaDepartment of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, ChinaNational Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, ChinaCollege of Medicine and Biological Information Engineering, Northeastern University, Shenyang, Liaoning, ChinaDepartment of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, ChinaNational Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, ChinaDepartment of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, ChinaObjectivesThe primary goal of this research was to design a useful and biocompatible nanofilm system (CNF) encapsulating chlorhexidine acetate (CHX) for wounds that is endowed with antibacterial and anti-inflammatory activities and promotes wound healing.MethodsThe nanofilm system was developed on the basis of the successful preparation of its nanoemulsion and PVA-CS film system and then important properties of the nanofilm system, including its morphological and physicochemical characteristics, stability and safety, its antimicrobial efficacy against P. aeruginosa was also evaluated in vitro and in vivo. The antibacterial effect, wound healing effect and inflammatory factor change in vivo were evaluated.ResultsThese results of this nanofilm system revealed a good particle size (59.27 nm) and stable zeta potential (−15.2 mV) that are suitable for wound healing applications. Additionally, it was stable, exhibited long-term stability (24 months) and sustained release in simulated wound fluid. Results showed that this nanofilm does not induce dose-related toxic effects and displays a better antibacterial effect that occurs more quickly, two times greater than that of CHX in vitro. This safe nanofilm enhances antibacterial activity against P. aeruginosa for 14 days, modulates the immune response, and accelerates skin wound healing in vivo.ConclusionsThese insights into multifunctional nanofilm designs for improved antibacterial effects and sustained release suggest promising clinical applications.https://www.frontiersin.org/articles/10.3389/fmicb.2025.1548106/fullmultidrug-resistant bacterialPseudomonas aeruginosananofilmantibacterial effectwound heal |
| spellingShingle | Feifei Lu Guoxiu Lu Zhiguo Wang Wenzhua Wei Jingjing Chen Hailin Zheng Xuesong Liu Yan Ye Shuling Liu Yuxiang Lin Yuxin Liu Zhanhua Bi Quanming Zou Guoxu Zhang Guoxu Zhang Hongwu Sun Yanan Tong Improved antibacterial activity of a sustained-release biocompatible nanofilm for treating Pseudomonas aeruginosa wound infection in vitro and in vivo Frontiers in Microbiology multidrug-resistant bacterial Pseudomonas aeruginosa nanofilm antibacterial effect wound heal |
| title | Improved antibacterial activity of a sustained-release biocompatible nanofilm for treating Pseudomonas aeruginosa wound infection in vitro and in vivo |
| title_full | Improved antibacterial activity of a sustained-release biocompatible nanofilm for treating Pseudomonas aeruginosa wound infection in vitro and in vivo |
| title_fullStr | Improved antibacterial activity of a sustained-release biocompatible nanofilm for treating Pseudomonas aeruginosa wound infection in vitro and in vivo |
| title_full_unstemmed | Improved antibacterial activity of a sustained-release biocompatible nanofilm for treating Pseudomonas aeruginosa wound infection in vitro and in vivo |
| title_short | Improved antibacterial activity of a sustained-release biocompatible nanofilm for treating Pseudomonas aeruginosa wound infection in vitro and in vivo |
| title_sort | improved antibacterial activity of a sustained release biocompatible nanofilm for treating pseudomonas aeruginosa wound infection in vitro and in vivo |
| topic | multidrug-resistant bacterial Pseudomonas aeruginosa nanofilm antibacterial effect wound heal |
| url | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1548106/full |
| work_keys_str_mv | AT feifeilu improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT guoxiulu improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT zhiguowang improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT wenzhuawei improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT jingjingchen improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT hailinzheng improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT xuesongliu improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT yanye improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT shulingliu improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT yuxianglin improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT yuxinliu improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT zhanhuabi improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT quanmingzou improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT guoxuzhang improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT guoxuzhang improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT hongwusun improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo AT yanantong improvedantibacterialactivityofasustainedreleasebiocompatiblenanofilmfortreatingpseudomonasaeruginosawoundinfectioninvitroandinvivo |